Blood transfusion safety in sub-Saharan Africa: A literature review of changes and challenges in the 21st century

Transfusion

Volumn 59, Issue 1, 2019, Pages 412-427

  Weimer, A ^a   Tagny, C T ^b   Tapko, J B ^c   Gouws, C ^d   Tobian, A A R ^a   Ness, P M ^a   Bloch, E M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University Teaching Hospital Yaounde   (Cameroon)

^c African Society of Blood Transfusion   (Cameroon)

^d Namibian Blood Transfusion Service   (Namibia)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ADULT; AFRICA SOUTH OF THE SAHARA; BLOOD SAFETY; BLOOD TRANSFUSION; CIRCULATION; FEMALE; FUNDING; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION; AFRICA; COMMUNICABLE DISEASE; PROCEDURES; TRANSMISSION;

AFRICA; AFRICA SOUTH OF THE SAHARA; BLOOD SAFETY; BLOOD TRANSFUSION; COMMUNICABLE DISEASES; HUMANS;

EID: 85059683943     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14949     Document Type: Review

References (124)

1. WHO. 19th WHO model list of essential medications (April 2015). WHO; 2015. [accessed 2018 Jan 20] Available from http://www.who.int/medicines/publications/essentialmedicines/en/.
2. Idro R, Aloyo J. Manifestations, quality of emergency care and outcome of severe malaria in Mulago Hospital. Uganda, Afr Health Sci 2004;4:50-7.
3. Scott GB, Brogly SB, Muenz D, et al. International Maternal Pediatric Adolescent ACTGPST. Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus. Obstet Gynecol 2017;129:621-8.
4. World Health Organization. Current status on blood safety and availability in the WHO African region—report of the 2013 survey. Geneva: World Health Organization; 2017:1-20. Licence: CC BY-NC-SA 3.0 IGO.
5. WHO. WHO global strategic plan, 2008–2015: universal access to safe blood transfusion. Geneva WHO, 2007. [accessed 2017 Dec 12] Available from http://www.who.int/bloodsafety/StrategicPlan2008-2015AccessSafeBloodTransfusion.pdf.
6. Chevalier MS, Kuehnert M, Basavaraju SV, et al. Progress toward strengthening national blood transfusion services – 14 countries, 2011–2014. MMWR Morb Mortal Wkly Rep 2016;65:115-9.
7. Sibinga CT. Existing and recommended legislative framework for a National Blood Transfusion Policy. Glob J Transfus Med 2017;2:89-96.
8. Bates I, Chapotera GK, McKew S, et al. Maternal mortality in sub-Saharan Africa: the contribution of ineffective blood transfusion services. BJOG 2008;115:1331-9.
9. Kiguli S, Maitland K, George EC, et al. Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness. BMC Med 2015;13:21.
10. Lund TC, Hume H, Allain JP, et al. The blood supply in Sub-Saharan Africa: needs, challenges, and solutions. Transfus Apher Sci 2013;49:416-21.
11. WHO Guidelines approved by the guidelines review committee towards 100% voluntary blood donation: a global framework for action. Geneva: World Health Organization; 2010.
12. Ala F, Allain JP, Bates I, et al. External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med 2012;9:e1001309.
13. Mapako T, Mvere DA, Chitiyo ME, et al. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety. Transfusion 2013;53:2413-21.
14. van den Berg K, Murphy EL, Pretorius L, et al. The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries. Transfus Apher Sci 2014;51:10-8.
15. Allain JP. Moving on from voluntary non-remunerated donors: who is the best blood donor? Br J Haematol 2011;154:763-9.
16. Tagny CT, Owusu-Ofori S, Mbanya D, et al. The blood donor in sub-Saharan Africa: a review. Transfus Med 2010;20:1-10.
17. Birhaneselassie M. Prevalence of transfusion-transmissible infections in donors to an Ethiopian Blood Bank between 2009 and 2013 and donation factors that would improve the safety of the blood supply in underdeveloped countries. Lab Med 2016;47:134-9.
18. Motayo BO, Faneye AO, Udo UA, et al. Seroprevalence of transfusion transmissible infections (TTI), in first time blood donors in Abeokuta, Nigeria. Afr Health Sci 2015;15:19-24.
19. Tagny CT, Diarra A, Yahaya R, et al. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion 2009;49:1592-9.
20. Asamoah-Akuoko L, Hassall OW, Bates I, et al. Blood donors’ perceptions, motivators and deterrents in sub-Saharan Africa – a scoping review of evidence. Br J Haematol 2017;177:864-77.
21. Alinon K, Gbati K, Sorum PC, et al. Emotional-motivational barriers to blood donation among Togolese adults: a structural approach. Transfus Med 2014;24:21-6.
22. Koster J, Hassall OW. Attitudes towards blood donation and transfusion in Bamenda, Republic of Cameroon. Transfus Med 2011;21:301-7.
23. Muthivhi TN, Olmsted MG, Park H, et al. Motivators and deterrents to blood donation among Black South Africans: a qualitative analysis of focus group data. Transfus Med 2015;25:249-58.
24. WHO. Global report on blood safety and availability. WHO; 2016. [Accessed 2018 Dec, 12] Available from http://apps.who.int/iris/bitstream/handle/10665/254987/9789241565431-eng.pdf.
25. Laperche S. Francophone African Group for Research in Blood T. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion 2013;53:816-26.
26. Prugger C, Laperche S, Murphy EL, et al. Screening for transfusion transmissible infections using rapid diagnostic tests in Africa: a potential hazard to blood safety? Vox Sang 2016;110:196-8.
27. Laperche S, Boukatou G, Kouegnigan L, et al. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion 2009;49:1600-8.
28. Bloch EM, Shah A, Kaidarova Z, et al. Anglophone Africa Transfusion Research Group. A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries. Vox Sang 2014;107:333-42.
29. Mbanya D. Use of quality rapid diagnostic testing for safe blood transfusion in resource-limited settings. Clin Microbiol Infect 2013;19:416-21.
30. WHO Guidelines approved by the guidelines review committee screening donated blood for transfusion-transmissible infections: recommendations. Geneva: World Health Organization; 2009.
31. Osaro E, Mohammed N, Zama I, et al. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria—the question of safety of blood transfusion in Nigeria. Pan Afr Med J 2014;18:174.
32. Oluyinka OO, Tong HV, Bui Tien S, et al. Occult hepatitis B virus infection in Nigerian blood donors and hepatitis B virus transmission risks. PLoS One 2015;10:e0131912.
33. Shittu AO, Olawumi HO, Adewuyi JO. Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains – experience at a resource limited blood bank. Ghana Med J 2014;48:158-62.
34. The World Bank; 2018. [Accessed 2018 March 16] Available from http://blogs.worldbank.org/ppps/category/countries/nigeria.
35. Gouws CNAMBTS. South African Blood Transfusion Congress. Sun City, South. Africa 2017.
36. Ware AD, Jacquot C, Tobian AA, et al. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sang 2018;113:3-12.
37. Economopoulou A, Dominguez M, Helynck B, et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on reunion. Epidemiol Infect 2009;137:534-41.
38. Owusu-Ofori S, Kusi J, Owusu-Ofori A, et al. Treatment of whole blood with riboflavin and UV light: impact on malaria parasite viability and whole blood storage. Shock 2015;44(Suppl 1):33-8.
39. Allain JP, Owusu-Ofori AK, Assennato SM, et al. Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet 2016;387:1753-61.
40. Drew VJ, Barro L, Seghatchian J, et al. Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries. Blood Transfus 2017;15:512-21.
41. Morar MM, Pitman JP, McFarland W, et al. The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub-Saharan Africa: reexamination of the 5% to 10% convention. Transfusion 2016;56:3121-32.
42. Apata IW, Averhoff F, Pitman J, et al. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection: sub-Saharan Africa, 2000–2011. MMWR Morb Mortal Wkly Rep 2014;63:613-9.
43. Organization WH. Global hepatitis report, 2017. Geneva: World Health Organization; 2017 [accessed 2018 Feb 5]. Available from http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/.
44. Nna E, Mbamalu C, Ekejindu I. Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria. Pathog Global Health 2014;108:223-8.
45. Lopes T, Cable R, Pistorius C, et al. Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype? Epidemiol Infect 2017;145:1910-2.
46. Al-Sadeq DW, Majdalawieh AF, Nasrallah GK. Seroprevalence and incidence of hepatitis E virus among blood donors: a review. Rev Med Virol 2017;27:e1937.
47. Boon D, Redd AD, Laeyendecker O, et al. Rakai Health Sciences P. Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda. J Infect Dis 2018;217:785-9.
48. Diarra AB, Kouriba B, Guindo A, et al. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: implications for blood safety. Transfus Clin Biol 2014;21:139-42.
49. Watanabe T. Current status of HTLV-1 infection. Int J Hematol 2011;94:430-4.
50. Fox JM, Mutalima N, Molyneux E, et al. Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa. Trop Med Int Health 2016;21:312-24.
51. Etenna SL, Caron M, Besson G, et al. New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa. J Clin Microbiol 2008;46:3607-14.
52. Mahieux R, Horal P, Mauclere P, et al. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection. J Clin Microbiol 2000;38:4049-57.
53. Murphy EL. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): implications for blood transfusion safety. Transfus Clin Biol 2016;23:13-9.
54. Emery VC. Investigation of CMV disease in immunocompromised patients. J Clin Pathol 2001;54:84-8.
55. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
56. Ziemann M, Thiele T. Transfusion-transmitted CMV infection - current knowledge and future perspectives. Transfus Med 2017;27:238-48.
57. Bolarinwa RA, Donbraye E, Ademosu AA, et al. Prevalence and associated characteristics of cytomegalovirus (Cmv) immunoglobulin antibodies among blood donors at a University Teaching Hospital in Nigeria. East Afr Med J 2014;91:385-90.
58. Vamvakas EC. Is human herpesvirus-8 transmitted by transfusion? Transfus Med Rev 2010;24:1-14.
59. Dollard SC, Butler LM, Jones AM, et al. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the “Kaposi's sarcoma belt”. Int J Cancer 2010;127:2395-401.
60. Hladik W, Dollard SC, Mermin J, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006;355:1331-8.
61. Gobbini F, Owusu-Ofori S, Marcelin AG, et al. Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa. Transfusion 2012;52:2294-9.
62. Shang G, Biggerstaff BJ, Richardson AM, et al. A simulation model to estimate the risk of transfusion-transmitted arboviral infection. Transfus Apher Sci 2016;55:233-9.
63. Baba M, Villinger J, Masiga DK. Repetitive dengue outbreaks in East Africa: a proposed phased mitigation approach may reduce its impact. Rev Med Virol 2016;26:183-96.
64. Otshudiema JO, Ndakala NG, Mawanda EK, et al. Yellow fever outbreak – Kongo Central Province, Democratic Republic of the Congo, August 2016. MMWR Morb Mortal Wkly Rep 2017;66:335-8.
65. Petersen LR, Stramer SL, Powers AM. Chikungunya virus: possible impact on transfusion medicine. Transfus Med Rev 2010;24:15-21.
66. Moyen N, Thiberville SD, Pastorino B, et al. First reported Chikungunya fever outbreak in the Republic of Congo, 2011. PLoS One 2014;9:e115938.
67. Jimenez A, Shaz BH, Bloch EM. Zika virus and the blood supply: what do we know. Transfus Med Rev 2017;31:1-10.
68. Simonin Y, Loustalot F, Desmetz C, et al. Zika virus strains potentially display different infectious profiles in human neural cells. EBioMedicine 2016;12:161-9.
69. Nutt C, Adams P. Zika in Africa-the invisible epidemic? Lancet 2017;389:1595-6.
70. Abdullah S, Karunamoorthi K. Ebola and blood transfusion: existing challenges and emerging opportunities. Eur Rev Med Pharmacol Sci 2015;19:2983-96.
71. van Griensven J, De Weiggheleire A, Delamou A, et al. The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field. Clin Infect Dis 2016;62:69-74.
72. Burnouf T, Emmanuel J, Mbanya D, et al. Ebola: a call for blood transfusion strategy in sub-Saharan Africa. Lancet 2014;384:1347-8.
73. Tagny CT. Syphilis and blood safety in developing countries. In: Sato N, editors. Syphilis-recognition description and diagnosis. London, United Kingdom: InTech; 2011.
74. Owusu-Ofori AK, Parry CM, Bates I. Transfusion-transmitted syphilis in teaching hospital, Ghana. Emerg Infect Dis 2011;17:2080-2.
75. Sarkodie F, Hassall O, Owusu-Dabo E, et al. Syphilis screening practices in blood transfusion facilities in Ghana. Int J Infect Dis 2016;43:90-4.
76. Sarkodie F, Ullum H, Owusu-Dabo E, et al. A novel strategy for screening blood donors for syphilis at Komfo Anokye Teaching Hospital, Ghana. Transfus Med 2016;26:63-6.
77. Makuni N, Simango C, Mavenyengwa RT. Prevalence of bacterial contamination in blood and blood products at the National Blood Service Zimbabwe. J Infect Dev Ctries 2015;9:421-4.
78. Hume HA, Ddungu H, Angom R, et al. Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions. Transfusion 2016;56:1951-9.
79. Bolarinwa RAAO, Odeloyin BW, Adegunloye AB. Bacterial contamination of blood and blood components in a tertiary hospital setting in Nigeria. Int J Infect Control 2011;7:1-6.
80. Adjei AA, Kuma GK, Tettey Y, et al. Bacterial contamination of blood and blood components in three major blood transfusion centers, Accra. Ghana. Jpn J Infect Dis 2009;62:265-9.
81. Hassall O, Maitland K, Pole L, et al. Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital. Transfusion 2009;49:2594-8.
82. Opoku-Okrah C, Feglo P, Amidu N, et al. Bacterial contamination of donor blood at the Tamale Teaching Hospital, Vol. 9. Ghana: Afr Health Sci; 2009. p. 13-8.
83. Esmael ADZ, Degu G. Bacterial Contamination of Stored Blood Ready for Transfusion at a Referral Hospital in Ethiopia. J Clin Res Bioeth 2014;5:176-9.
84. Matte Aloysius GBJB, Apecu R, Yap B, et al. Bacterial Contamination of blood and blood products at Mbarara Regional blood bank in rural South Western Uganda. Adv Infect Dis 2013;3:205-9.
85. Owusu-Ofori AK, Parry C, Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis 2010;51:1192-8.
86. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev 2012;26:164-80.
87. Allain JP, Assennato SM, Osei EN, et al. Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients. Transfusion 2016;56:2374-83.
88. Noubouossie D, Tagny CT, Same-Ekobo A, et al. Asymptomatic carriage of malaria parasites in blood donors in Yaounde. Transfus Med 2012;22:63-7.
89. Freimanis G, Sedegah M, Owusu-Ofori S, et al. Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion 2013;53:1429-41.
90. Ayogu EE, Ukwe CV, Nna EO. Assessing the reliability of microscopy and rapid diagnostic tests in malaria diagnosis in areas with varying parasite density among older children and adult patients in Nigeria. J Postgrad Med 2016;62:150-6.
91. Allain JP. Malaria and transfusion: a neglected subject coming back to the forefront. Clin Infect Dis 2010;51:1199-200.
92. Bregani ER. Filariasis due to blood transfusion. Blood Transfus 2010;8:129.
93. Wiwanitkit V. Filariasis due to blood transfusion: a topic in tropical medicine. Blood Transfus 2009;7:151.
94. Bregani ER, Balzarini L, Ghiringhelli C, et al. Transfusional Mansonella perstans microfilariasis. Parassitologia 2003;45:71-2.
95. Apata IW, Drammeh B, De AK, et al. Diagnoses and ordering practices driving blood demand for treatment of anemia in Tanzania. Transfusion 2018;58:379-89.
96. Nebie K, Ouattara S, Sanou M, et al. Poor procedures and quality control among nonaffiliated blood centers in Burkina Faso: an argument for expanding the reach of the national blood transfusion center. Transfusion 2011;51:1613-8.
97. Smit Sibinga CT, Adejumo OH, Eichbaum Q, et al. A global survey of clinicians' awareness, accessibility, utilization of e-continuous education, and quality of clinical blood use: policy considerations. Int J Clin Transfus Med 2017;5:69-82.
98. Makani J, Lyimo M, Magesa P, et al. Strengthening medical education in haematology and blood transfusion: postgraduate programmes in Tanzania. Br J Haematol 2017;177:838-45.
99. Bloch E. African Society for Blood Transfusion Education Committee South African Blood Tranfusion Conference. Sun City, South. Africa 2017.
100. African Society for Blood Transfusion. 2016. [accessed 2018 Feb 10] Available from https://afsbt.org/.
101. Ifland L, Bloch EM, Pitman JP. Funding blood safety in the 21st century. Transfusion 2017;58:105-12.
102. PEPFAR. 2017. [accessed 2018 Jan 24] Available from https://data.pepfar.net/global.
103. Coordinator USGA. PEPFAR Dashboards. Wasington, DC: PEPFAR [accessed 2018 Jan 24] Available from: https://www.pepfar.gov/.
104. Drammeh B, De A, Bock N, et al. Estimating Tanzania's national met and unmet blood demand from a survey of a representative sample of hospitals. Transfus Med Rev 2018;32:36-42.
105. Mafirakureva N, Nyoni H, Nkomo SZ, et al. The costs of producing a unit of blood in Zimbabwe. Transfusion 2016;56:628-36.
106. Bates I, Hassall O, Mapako T. Transfusion research priorities for blood services in sub-Saharan Africa. Br J Haematol 2017;177:855-63.
107. Custer B, Zou S, Glynn SA, et al. Addressing gaps in international blood availability and transfusion safety in low- and middle-income countries: a NHLBI workshop. Transfusion 2018;58:1307-17.
108. Murphy EL, McFarland W, Lefrere JJ. Teaching transfusion medicine research methods in the developing world. Transfusion 2009;49:1532-4.
109. Sibinga CT. Filling a gap in transfusion medicine education and research. Transfus Med Rev 2009;23:284-91.
110. Nagalo BM, Bisseye C, Sanou M, et al. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health 2012;17:247-53.
111. Nagalo MB, Sanou M, Bisseye C, et al. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus 2011;9:419-24.
112. Noubiap JJ, Joko WY, Nansseu JR, et al. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edea, Cameroon. Int J Infect Dis 2013;17:e832-7.
113. Kabinda JM, Michele DW, Donnen P, et al. Factors for viral infection in blood donors of South Kivu in the Democratic Republic of Congo. Pan Afr Med J 2014;19:385.
114. Xie DD, Li J, Chen JT, et al. Seroprevalence of human immunodeficiency virus, hepatitis B virus, Hepatitis C virus, and Treponema pallidum infections among blood donors on Bioko Island, Equatorial Guinea. PLoS One 2015;10:e0139947.
115. Fessehaye N, Naik D, Fessehaye T. Transfusion transmitted infections - a retrospective analysis from the National Blood Transfusion Service in Eritrea. Pan Afr Med J 2011;9:40.
116. Abate M, Wolde T. Seroprevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis among blood donors at Jigjiga Blood Bank, Eastern Ethiopia. Ethiop J Health Sci 2016;26:153-60.
117. Biadgo B, Shiferaw E, Woldu B, et al. Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: a three year retrospective study. PLoS One 2017;12:e0180416.
118. Rerambiah LK, Rerambiah LE, Bengone C, et al. The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. Blood Transfus 2014;12:330-3.
119. Kubio C, Tierney G, Quaye T, et al. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District. Transfusion 2012;52:2161-6.
120. Stokx J, Gillet P, De Weggheleire A, et al. Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infect Dis 2011;11:141.
121. Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus 2009;7:293-9.
122. Vermeulen M, Swanevelder R, Chowdhury D, et al. Use of blood donor screening to monitor prevalence of HIV and hepatitis B and C viruses, South Africa. Emerg Infect Dis 2017;23:1560-3.
123. Ben Jemia R, Gouider E. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia. Transfus Clin Biol 2014;21:303-8.
124. Allain JP. Volunteer safer than replacement donor blood: a myth revealed by evidence. ISBT Sci Ser 2010;5:169-75.